Zepbound vs. Mounjaro For Weight Loss: What’s The Difference?

Mounjaro and Zepbound are two brand-name glucagon-like peptide-1 (GLP-1) medications manufactured by Eli Lilly. Although they ...
Zacks Investment Research on MSN

Can Mounjaro, Zepbound & Foundayo keep fueling LLY's growth story?

Eli Lilly LLY has emerged as a dominant force in the cardiometabolic market, driven by strong demand for its blockbuster ...

Why Zepbound became the first drug FDA-cleared specifically for obstructive sleep apnea

New research shows Ozempic may reduce sleep apnea severity by over 50%. Here's what the science actually says.

There’s a ‘powerful’ new weight-loss drug. A new study shows it produced 28% weight loss.

The injection is different than Zepbound and Foundayo.

Eli Lilly and its gambit to stay on top of the GLP-1 heap

However, Eli Lilly launched its own weight loss pill, orforglipron, marketed as Foundayo, in April. And the company has ...

From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook

Eli Lilly just got more good news, posting promising results for its oral GLP-1 as the firm looks to unlock new sources of ...

Can Eli Lilly Stock Reach $1800 by 2030? Here Is the Bull Case

Eli Lilly (NYSE:LLY) is growing like a software company. Q1 2026 revenue hit $19.80B, up 55.5% year over year, with Mounjaro ...
Medical News Today

Zepbound vs. Wegovy: How these drugs compare

Zepbound and Wegovy treat weight loss and weight management in adults with obesity or overweight. Both drugs are also approved to treat other conditions. These drugs are given as weekly injections, ...

Zepbound vs. Wegovy For Weight Loss: What’s The Difference?

If you’re weighing the option of Wegovy versus Zepbound for weight loss, here’s how the two medications compare in terms of ...